Serum Life Science Europe Gmbh

This early-stage trial tested a single dose of a new whole-cell pneumonia vaccine in 30 healthy adults aged 18 to 49. The main goal was to see if the vaccine is safe and tolerable. Participants were monitored for 30 days after vaccination, and researchers compared side effects be…

This study tested whether a vaccine called VPM1002, based on the old tuberculosis vaccine BCG, could reduce sick days in healthcare workers exposed to COVID-19. About 59 hospital staff received either the vaccine or a placebo. The goal was to see if the vaccine could boost the im…